Objective: 

To evaluate the effects of acute and chronic supplementation with cognitaven® on cognitive performance, mood, and stress response in healthy adults.

Methods: 

Participants: 132 (acute) / 126 (chronic) healthy volunteers (males and females)

Dosage: 430mg、860mg、1290mg dosages of cognitaven® and placebo

Study Type: dose-ranging, randomized, double-Blind, placebo-controlled study

Duration: acute (1day) and chronic (29 days) testing

Results:

cognitaven® showed significant improvement

→ in cognitive function and multitasking under acute and chronic treatment

→ in specific stress parameters under chronic treatment.